Showing results (11-20 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|December 19, 2022
Synthetic opioids: a review and clinical updateAbu Shafi, Alex J Berry, Harry Sumnall, et al.Therapeutic Advances in Psychopharmacology|May 22, 2020
How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confoundingMichael P HengartnerTherapeutic Advances in Psychopharmacology|September 2, 2021
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort studyPeter C Groot, Jim van OsTherapeutic Advances in Psychopharmacology|July 23, 2015
Five-year patient outcomes with risperidone long-acting injection or oral aripiprazolePaul Nicholas Deslandes, Matthew Dwivedi, Robert D E SewellTherapeutic Advances in Psychopharmacology|July 23, 2015
Effect of comedication of bupropion and other antidepressants on body mass indexPriyadarshini P Ravindran, Wenzhao Zang, Swetha Renukunta, et al.Therapeutic Advances in Psychopharmacology|June 18, 2020
Resolution without discontinuation: heart failure during clozapine treatmentEromona Whiskey, Shirley Yuen, Emma Khosla, et al.Therapeutic Advances in Psychopharmacology|August 19, 2016
Vitamin D status of adolescent inpatients in a secure psychiatric hospitalSimon A Hill, Elliott Riordan-Eva, Bharathi Bhandari, et al.Therapeutic Advances in Psychopharmacology|September 2, 2025
Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databasesFrank Andersohn, Pedro Such, Michael Jan, et al.Therapeutic Advances in Psychopharmacology|August 5, 2021
Liquorice for pain?Rae F Bell, Vânia M Moreira, Eija A Kalso, et al.Therapeutic Advances in Psychopharmacology|March 10, 2023
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidenceAnya Ragnhildstveit, Jeremy Roscoe, Lisa C Bass, et al.Pageof 55